LOS ANGELES, California, Nov. 10 (TNSjou) -- The UCLA Health Jonsson Comprehensive Cancer Center issued the following news release:

* * *

New drug combination improves survival in patients with muscle-invasive bladder cancer

Study finds that combining immunotherapy with a targeted cancer drug before surgery, followed by immunotherapy, reduces the risk of death by 42% in patients unable to receive standard chemotherapy

November 9, 2026